Treatment of presumed fungal endophthalmitis with oral fluconazole

Ophthalmic Surgery and Lasers

Volumn 27, Issue 7, 1996, Pages 628-631

  Zarbin, Marco A ^a,c   Becker, Eleanor ^b   Witcher, Jack ^b   Yamani, Amir ^a   Irvine, Alexander R ^b  

^a INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; TRIAZOLE DERIVATIVE;

AGED; ANTIFUNGAL ACTIVITY; ARTICLE; CASE REPORT; CHORIORETINITIS; CLINICAL FEATURE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG HALF LIFE; ENDOPHTHALMITIS; HUMAN; MALE; MYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANTIFUNGAL AGENTS; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; FLUCONAZOLE; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; MALE; VISUAL ACUITY; VITREOUS BODY;

EID: 0030056829     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bennett JE, Chemotherapy of systemic mycoses. N Engl J Med. 1974;290:30-32, 320-322.
2. Axelrod AJ, Peyman GA, Apple DJ. Toxicity of intravitreal injection of amphotericin B. Am J Ophthalmol. 1973;76:578-583.
3. Souri EN, Green WR. Intravitreal amphotericin B toxicity. Am J Ophthalmol. 1974;78:77-81.
4. Green WR, Bennett JE, Goos RD. Ocular penetration of amphotericin B: a report of laboratory studies and a case report of postsurgical cephalosporum endophthalmitis. Arch Ophthalmol. 1965;73:769-775.
5. Savani DV, Perfect JR, Cobo LM, et al. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother. 1987;31:6-10.
6. Perfect JR, Savani DV, Durack DT. Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and Candida pyelonephritis in rabbits. J Antimicrob Chemother. 1986;29:579-583.
7. Fernandez EP, de Patino MM, Graybill JR, et al. Treatment of cryptococcal meningitis in mice with fluconazole. J Antimicrob Chemother. 1986;18:261-270.
8. Kobayashi GS, Travis S, Medoff G. Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK-49,858 with that of amphotericin B against Histoplasma capsulatum. Antimicrob Agent Chemother. 1986;29:660-662.
9. Richardson K, Brammer KW, Marriott MS, et al. Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes. Antimicrob Agents Chemother. 1985;27:832-835.
10. Troke PF, Andrews RJ, Marriott MS, et al. Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. J Antimicrob Chemother. 1987;19:663-670.
11. Griffin JR, Pettit TH, Fishman LS, et al. Blood-borne Candida endophthalmitis: a clinical and pathologic study of 21 cases. Arch Ophthalmol. 1973;89:450-456.
12. Edwards JE Jr, Foos RY, Montgomerie JZ, et al. Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis. Medicine. 1974;53:47-75.
13. Parke DW II, Jones DB, Genrty LO. Endogenous endophthalmitis among patients with candidemia. Ophthalmology. 1982;89:789-796.
14. McDonnell PJ, McDonnell JM, Brown RH, et al. Ocular involvement in patients with fungal infections. Ophthalmology. 1985;92:706-709.
15. Humphrey MJ, Jevons S, Tarbit MH. Pharmacokinetic valuation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans. Antimicrob Agents Chemother. 1985;28:648-653.
16. Investigator's Reference Manual: Fluconazole (UK-49,858) Antifungal, Oral and Intravenous. Groton CT: Pfizer Central Research; 1986.
17. Perfect JR, Durack DT. Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. J Antimicrob Chemother. 1985;16:81-86.
18. Foulds G, Brennan DR, Wajszczuk C, et al. Fluconazole penetration into cerebrospinal fluid in humans. J Clin Pharmacol. 1988;28:363-366.
19. O'Day DM, Foulds G, Williams TE, et al. Ocular uptake of fluconazole following oral administration. Arch Ophthalmol. 1990;108:1006-1008.
20. Luttrull JK, Lee Wan W, Kubak BM, Smith MD, Oster HA. Treatment of ocular fungal infections with oral fluconazole. Am J Ophthalmol. 1995;119:477-481.